Perioperative strategies and bleeding in joint replacement
Part of Bones, joints & muscles clinical trials.
This study checks how different care during and after joint replacement surgery affects bleeding. It focuses on people having their first hip or knee replacement who received a standard bleeding-control medicine (tranexamic acid).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and getting your first-ever hip or knee replacement.
- Your overall health is classified as ASA I, II, or III by your anesthesia team.
- You received tranexamic acid (a medicine to reduce bleeding) before and after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with inherited bleeding disorders, like hemophilia, do after joint replacement surgery. Researchers want to learn what works best for managing bleeding during and after surgery to improve recovery.
This study tests whether a medicine called tranexamic acid (TXA) can reduce pain, improve movement, and lessen bleeding after hip or knee replacement surgery. It is for adults having their first joint replacement at St. Mary's Hospital.
This study compares two ways of giving tranexamic acid (a medication that reduces bleeding) during hip or knee replacement surgery. Researchers want to see which method—injected directly into the bone or through the vein—works better and reaches the bloodstream more effectively.
This study tests whether a medicine called tranexamic acid (TXA), given as a shot into the hip joint or as a soak on the skin, can reduce bleeding during hip replacement surgery. It is for people over 60 who broke their hip from a simple fall and need a cementless hip replacement.
This trial tests an experimental drug called BT-114143 to see if it reduces bleeding during and after total knee replacement surgery. It may be a good option for people with osteoarthritis who are having their first knee replacement.
This trial tests whether taking tranexamic acid (a medicine that helps blood clot) for several days after knee replacement surgery reduces bleeding and improves recovery. It may help patients who have a standard knee replacement and are not on blood thinners.
Hear when a new Orthopaedic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.